PACIRA PHARMS INC Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PACIRA PHARMS INC, and when can generic versions of PACIRA PHARMS INC drugs launch?
PACIRA PHARMS INC has four approved drugs.
There are twelve US patents protecting PACIRA PHARMS INC drugs.
There are fifty-eight patent family members on PACIRA PHARMS INC drugs in twenty-three countries and eighteen supplementary protection certificates in eight countries.
Summary for PACIRA PHARMS INC
International Patents: | 58 |
US Patents: | 12 |
Tradenames: | 4 |
Ingredients: | 4 |
NDAs: | 4 |
Drugs and US Patents for PACIRA PHARMS INC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pacira Pharms Inc | EXPAREL | bupivacaine | INJECTABLE, LIPOSOMAL;INJECTION | 022496-001 | Oct 28, 2011 | RX | Yes | Yes | 11,278,494 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Pacira Pharms Inc | EXPAREL | bupivacaine | INJECTABLE, LIPOSOMAL;INJECTION | 022496-002 | Oct 28, 2011 | RX | Yes | Yes | 11,819,575 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Pacira Pharms Inc | EXPAREL | bupivacaine | INJECTABLE, LIPOSOMAL;INJECTION | 022496-002 | Oct 28, 2011 | RX | Yes | Yes | 11,304,904 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Pacira Pharms Inc | EXPAREL | bupivacaine | INJECTABLE, LIPOSOMAL;INJECTION | 022496-001 | Oct 28, 2011 | RX | Yes | Yes | 11,426,348 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Pacira Pharms Inc | EXPAREL | bupivacaine | INJECTABLE, LIPOSOMAL;INJECTION | 022496-001 | Oct 28, 2011 | RX | Yes | Yes | 11,033,495 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Pacira Pharms Inc | EXPAREL | bupivacaine | INJECTABLE, LIPOSOMAL;INJECTION | 022496-002 | Oct 28, 2011 | RX | Yes | Yes | 11,357,727 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PACIRA PHARMS INC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pacira Pharms Inc | DEPODUR | morphine sulfate | INJECTABLE, LIPOSOMAL;EPIDURAL | 021671-002 | May 18, 2004 | 5,931,809 | ⤷ Try a Trial |
Pacira Pharms Inc | DEPODUR | morphine sulfate | INJECTABLE, LIPOSOMAL;EPIDURAL | 021671-003 | May 18, 2004 | 5,723,147 | ⤷ Try a Trial |
Pacira Pharms Inc | EXPAREL | bupivacaine | INJECTABLE, LIPOSOMAL;INJECTION | 022496-001 | Oct 28, 2011 | 9,585,838 | ⤷ Try a Trial |
Pacira Pharms Inc | DEPOCYT | cytarabine | INJECTABLE, LIPOSOMAL;INJECTION | 021041-001 | Apr 1, 1999 | 5,455,044 | ⤷ Try a Trial |
Pacira Pharms Inc | DEPODUR | morphine sulfate | INJECTABLE, LIPOSOMAL;EPIDURAL | 021671-002 | May 18, 2004 | 5,723,147 | ⤷ Try a Trial |
Pacira Pharms Inc | DEPODUR | morphine sulfate | INJECTABLE, LIPOSOMAL;EPIDURAL | 021671-001 | May 18, 2004 | 5,723,147 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PACIRA PHARMS INC Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
China | 103260603 | ⤷ Try a Trial |
Uruguay | 33546 | ⤷ Try a Trial |
Japan | 2014521686 | ⤷ Try a Trial |
Taiwan | I548412 | ⤷ Try a Trial |
Japan | 2018024711 | ⤷ Try a Trial |
Japan | 2016190861 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for PACIRA PHARMS INC Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
3300601 | LUC00271 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: COMBINATION OF DAUNORUBICIN AND CYTARABINE; AUTHORISATION NUMBER AND DATE: EU/1/18/1308 20180827 |
1744764 | SPC/GB18/045 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: COMBINATION OF DAUNORUBICIN AND CYTARABINE; REGISTERED: UK EU/1/18/1308/001-003 20180827; UK PLGB 31626/0004 20180827 |
2768484 | 2019/054 | Ireland | ⤷ Try a Trial | PRODUCT NAME: COMBINATION OF DAUNORUBICIN AND CYTARABINE; REGISTRATION NO/DATE: EU/1/18/1308 20180827 |
1744764 | 300960 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: COMBINATIE VAN DAUNORUBICINE EN CYTARABINE; REGISTRATION NO/DATE: EU/1/18/1308 20180827 |
2768484 | SPC/GB19/067 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: COMBINATION OF DAUNORUBICIN AND CYTARABINE; REGISTERED: UK EU/1/18/1308(FOR NI) 20180827; UK PLGB 31626/0004 20180827 |
2768484 | 1990053-9 | Sweden | ⤷ Try a Trial | PRODUCT NAME: COMBINATION OF DAUNORUBICIN AND CYTARABINE; REG. NO/DATE: EU/1/18/1308 20180827 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.